ARVN
#2808
Arvinas, Inc. - Common Stock
9.1 8 USD
-0.01%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-0.65%
Monthly Change
+13.19%
6 month change
-28.56%
Year Change
-1.29%
Previous Close
9.2 4
Open
9.1 8
Low
9.1 8
High
9.1 8
Volume
50
Financials
- Market Capitalization 600.25 M
- Employee 246
- Founded 2013
- CEO N/A
- Website www.arvinas.com
- Headquarter Delaware, United States
- FIGI BBG00LW7YK82
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-10.4
Price to sales ratio
3.2
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2788 |  AUTL Autolus Therapeutics plc - American Depositary Shares | 2.34 USD | -0.85% | -2.50% | +60.27% | +58.11% | 622.82 M USD | ||
| 2800 |  ALT Altimmune, Inc. - Common Stock | 3.11 USD | -4.01% | 0.00% | +6.87% | -18.37% | 604.95 M USD | ||
| 2830 |  SPRY ARS Pharmaceuticals, Inc. - Common Stock | 5.89 USD | -2.32% | +9.07% | +1.55% | -36.05% | 585.74 M USD | ||
| 2831 |  MPLT MapLight Therapeutics, Inc. - Common Stock | 12.60 USD | +0.48% | +12.40% | -16.94% | -33.68% | 584.36 M USD |
Frequently asked questions about Arvinas, Inc
What is the Arvinas, Inc stock price today?
The current price of Arvinas, Inc (ARVN) is 9.18. Over the past 24 hours, the stock has changed by -0.65%. Follow the ARVN chart for real-time price dynamics.
What is the stock ticker of Arvinas, Inc?
Arvinas, Inc trades under the ticker ARVN. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Arvinas, Inc stock going up?
ARVN has changed by -2.13% over the last week, +13.19% over the last month, and -1.29% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Arvinas, Inc?
Arvinas, Inc currently has a market capitalization of 600.25 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Arvinas, Inc earnings last quarter?
Last quarter, Arvinas, Inc reported earnings of 2.61 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Arvinas, Inc revenue for the last quarter?
Arvinas, Inc reported quarterly revenue of 249.7 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Arvinas, Inc net income for the last quarter?
Arvinas, Inc reported net income of 169.4 M for the last quarter. The previous quarter showed -57.6 M, which means net income changed by +394.10%.
How many employees does Arvinas, Inc have?
As of the latest available data, Arvinas, Inc has 246 employees. Workforce size can provide additional context about the company's scale and operations.
What is Arvinas, Inc EBITDA?
Arvinas, Inc EBITDA is 162.6 M, and its EBITDA margin is 65.12%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Arvinas, Inc stock?
You can buy Arvinas, Inc (ARVN) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Arvinas, Inc stock?
Investing in Arvinas, Inc requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ARVN chart and related analysis on metatrader.com as part of your research.